Effect of Citalopram on Chest Pain in Patients With Functional Chest Pain (Ci-FCP)
Functional Chest Pain
About this trial
This is an interventional treatment trial for Functional Chest Pain
Eligibility Criteria
Inclusion Criteria: Written informed consent Minimum age: 18 years Functional chest pain according to Rome IV criteria Ruled out cardiac origin of chest pain ECG with corrected QT interval (QTc) within the normal range (<450ms male, <460ms female) Symptoms of chest pain for at least 6 months Frequency of symptoms at least once a week Gastroduodenoscopy, high-resolution manometry and 24-hour pH-impedance monitoring need to have been performed recently. Exclusion Criteria: Currently using antidepressants Contraindication for the use of SSRI Already tried antidepressants off-label to treat chest pain Known allergy to citalopram Severe and clinically unstable concomitant disease Pregnant, lactating or fertile women (without contraception)
Sites / Locations
- Amsterdam UMC, location AMC
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
Citalopram 20mg
Placebo